Bansag, Glysdi .
HRN: 24-07-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
CEFUROXIME 1.5GM (VIAL)
11/10/2023
11/17/2023
IV
1.3gm
Q 8hrs
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes